(Updated - October 31, 2022 6:48 AM EDT)

Guggenheim analyst Kelsey Goodwin initiates coverage on Century Therapeutics (NASDAQ: IPSC) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE